Bosh sahifa603087 ā¢ SHA
add
Gan & Lee Pharmaceuticals
Yopilish kursi
51,52Ā Ā„
Kunlik diapazon
51,30Ā Ā„ - 54,10Ā Ā„
Yillik diapazon
37,63Ā Ā„ - 54,10Ā Ā„
Bozor kapitalizatsiyasi
30,97Ā mlrd CNY
OŹ»rtacha hajm
12,06Ā mln
Narx/foyda
37,42
Dividend daromadliligi
-
Asosiy maydon
SHA
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 984,87Ā mln | 75,76% |
Joriy xarajat | 532,52Ā mln | 32,00% |
Sof foyda | 311,92Ā mln | 224,90% |
Sof foyda marjasi | 31,67 | 84,88% |
Har bir ulushga tushum | ā | ā |
EBITDA | 286,18Ā mln | 378,23% |
Amaldagi soliq stavkasi | 13,45% | ā |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,36Ā mlrd | -51,91% |
Jami aktivlari | 12,28Ā mlrd | 4,82% |
Jami passivlari | 972,31Ā mln | 10,82% |
Umumiy kapital | 11,31Ā mlrd | ā |
Tarqatilgan aksiyalar | 588,53Ā mln | ā |
Narxi/balansdagi bahosi | 2,68 | ā |
Aktivlardan daromad | 4,59% | ā |
Kapitaldan daromad | 4,99% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 311,92Ā mln | 224,90% |
Operatsiyalardan naqd pul | 158,75Ā mln | 95,29% |
Sarmoyadan naqd pul | 27,24Ā mln | 194,27% |
Moliyadan naqd pul | -75,21Ā mln | -7Ā 801,18% |
Naqd pulning sof oŹ»zgarishi | 112,24Ā mln | 118,03% |
BoŹ»sh pul | -180,96Ā mln | 16,06% |
Haqida
Tashkil etilgan
17-iyn, 1998
Sayt
Xodimlar soni
5Ā 245
